Pharma channel feed – Endpoints News

Pharma channel feed

J&J opens up conversations around depression in the LGBTQ+ community with new campaign

4 years ago

Amid rising concern of resistance, Pfizer limits supply of Paxlovid for combination studies — report

4 years ago

Despite federal efforts to diversify clinical trials, progress remains 'stagnant' — report

4 years ago

Bavarian Nordic secures BARDA contract for smallpox vaccine

4 years ago

AbbVie expands use of real patients in latest Allergan Aesthetics DTC campaign

4 years ago

New FTC commissioner could turn the tide for an investigation into PBMs

4 years ago

Senate user fee reauthorization bill omits accelerated approval reforms, shows wide gaps with House version

4 years ago

As new C. diff treatments prep for market, specialists divided on 'poop in a pill' or small molecule, study finds

4 years ago

Berkshire Hathaway pulls out of AbbVie, Bristol Myers Squibb investments

4 years ago

Long-expected UK layoffs imminent for Novartis following sale

4 years ago

FDA authorizes booster dose of Pfizer and BioNTech's Covid-19 vaccine in 5- to 11-year-olds

4 years ago

Greece goes on offensive against Novartis, filing a lawsuit in aftermath of bribery scheme

4 years ago

Pricy inhalers remain expensive due to device tweaks that keep competitors at bay, researchers find

4 years ago

MRx roundup: Hologic enlists Sheryl Crow for screenings; J&J QuickFire teams with feds for public health

4 years ago

Perpetual crisis? Pharma communications and public relations pros just wait for the next shoe to drop

4 years ago

A long time coming: GlaxoSmithKline officially changes name to GSK

4 years ago

Moderna blindsided by investigation into former CFO Jorge Gomez, company says

4 years ago

Roche lays out access ambitions in its ESG strategies, including innovation and value goals

4 years ago

Indian drugmaker seeks to toss 'bloated' billion-dollar lawsuit over Covid vaccine candidate

4 years ago

Aldevron and Inscripta ink manufacturing deal for CRISPR Type-V nuclease

4 years ago

French court rules against Sanofi in landmark Depakine case

4 years ago

AstraZeneca, Avillion detail the pivotal combo asthma data they're taking to the FDA

4 years ago

Emergent inks $225M cash smallpox deal as Chimerix implodes on reorg, FDA trouble

4 years ago

Billionaire Athira backer Ric Kayne suspends activist campaign — but shareholders can still vote for him

4 years ago

First page Previous page 199 200 201202203 204 205 Next page Last page